AslanNCGulerSDemirciK, et al. Features of terra firma-forme dermatosis. Ann Fam Med. 2018;16:52-54.
3.
BadaróBADinizLMNogueiraPSE. Terra firma-forme dermatosis: an underdiagnosed condition. An Bras Dermatol. 2020;95(3):397-399. doi:10.1016/j.abd.2019.07.013.
4.
SechiAPatriziASavoiaFLeuzziMGuglielmoANeriI.Terra firma-forme dermatosis: a systematic review. Int J Dermatol. 2020;60:933-943. doi:10.1111/ijd.15301.
BerkDRBrucknerAL.Terra firma-forme dermatosis in a 4-month-old girl. Pediatr Dermatol. 2011;28(1):79-81.
7.
StiubeAJenniDWiederkehrR, et al. Terra firma-forme dermatosis diagnostic sign and treatment: a case report. Case Rep Dermatol. 2019;11:108-112. doi:10.1159/000499897.
8.
ElmasOFUyarBKilitciAKutluO.Dermoscopic patterns of terra firma-forme dermatosis. Dermatol Online J. 2020;26(5):13030/qt6j78216z.
9.
VakirlisETheodosiouGLallasAApallaZSotiriouE.Terra firma-forme dermatosis: differential diagnosis and response to salicylic acid therapy. Pediatr Dermatol. 2019;36(4):501-504. doi:10.1111/pde.13807.
10.
PatrunoCFerrilloMFabbrociniGNapolitanoM.A case of dirty neck in severe and diffuse atopic dermatitis successfully treated with dupilumab. Dermatol Ther. 2021;34(1):e14556. doi:10.1111/dth.14556.
11.
SeghersACLeeJSTanCS, et al. Atopic dirty neck or acquired atopic hyperpigmentation? an epidemiological and clinical study from the National Skin Centre in Singapore. Dermatology. 2014;229:174-182. doi:10.1159/000362596.
12.
HiraKSugaYMonmaTMitsuishiKOgawaH.Tacrolimus ointmentin the treatment of dirty neck lesions in atopic dermatitis. J Am Acad Dermatol. 2005;52:720-722.
DasADattaDKassirM, et al. Acanthosis nigricans: a review. J Cosmet Dermatol. 2020;19(8):1857-1865. doi:10.1111/jocd.13544.
16.
LeungAKBarankinBLamJMLeongKFHonKL.Tinea versicolor: an updated review. Drugs Context. 2022;11:2022-9-2. doi:10.7573/dic.2022-9-2.
17.
SchwartzRA.Acanthosis nigricans. J Am Acad Dermatol. 1994;31(1):1-19.
18.
LeCBedocsPM.Confluent and Reticulated Papillomatosis. Treasure Island, FL: StatPearls Publishing; 2022.
19.
BanjarTAAbdulwahabRAAl HawsawiKA.Confluent and reticulated papillomatosis of gougerot and carteaud: a case report and review of the literature. Cureus. 2022;14(4):e24557. doi:10.7759/cureus.24557.
20.
Aghaei GharehbolaghSMafakherLSalehiZ, et al. Unveiling the structure of GPI-anchored protein of Malassezia globosa and its pathogenic role in pityriasis versicolor. J Mol Model. 2021;27(9):246. doi:10.1007/s00894-021-04853-7.
21.
GuptaAKLyonsDC.Pityriasis versicolor: an update on pharmacological treatment options. Expert Opin Pharmacother. 2014;15(12):1707-1713. doi:10.1517/14656566.2014.931373.
22.
GuptaAKLaneDPaquetM.Systematic review of systemic treatments for tinea versicolor and evidence-based dosing regimen recommendations. J Cutan Med Surg. 2014;18(2):79-90. doi:10.2310/7750.2013.13062.
23.
KangBYIbrahimSAShokeenD, et al. Postinflammatory hyperpigmentation: protocol for development of a core outcome set for clinical trials. Arch Dermatol Res. 2022;314(4):357-361. doi:10.1007/s00403-021-02239-6.
24.
Silpa-archaNKohliIChaowattanapanitSLimHWHamzaviI.Postinflammatory hyperpigmentation: a comprehensive overview. J Am Acad Dermatol. 2017;77:591-605. doi:10.1016/j.jaad.2017.01.035.
25.
KaplanRL.Omphalitis: clinical presentation and approach to evaluation and management. Pediatr Emerg Care. 2023;39(3):188-189. doi:10.1097/PEC.0000000000002918.
JaffarHShakirZKumarGAliIF.Ichthyosis vulgaris: an updated review. Skin Health Dis. 2022;3(1):e187. doi:10.1002/ski2.187.
28.
DiazLZBrowningJCSmidtACRizzoWBLevyML.Complications of ichthyosis beyond the skin: non-cutaneous complications of ichthyosis. Dermatol Ther. 2013;26(1):39-45. doi:10.1111/j.1529-8019.2012.01517.x.